Profile
Copoly.ai is a Canadian biotechnology and AI company redefining early cancer detection through its flagship product, OncoSage. Most cancers are diagnosed too late due to invasive, costly, and insensitive diagnostic methods. OncoSage addresses this by offering a non-invasive, AI-powered blood test that detects multiple cancers—including lung, breast, and colorectal—at Stage I with over 90% accuracy. Clinicians can use OncoSage to screen patients with a simple blood draw, receiving a detailed diagnostic report within two weeks. The report identifies cancer type (potentially subtype), and stage—enabling faster, more accurate clinical decision-making.
Unlike competitors relying on ctDNA, OncoSage leverages more robust biological signals found earlier in disease progression, making it suitable for population-level screening and routine use. With its accuracy, speed, accessibility, and patient-friendliness, OncoSage empowers healthcare systems to act earlier—improving survival outcomes and reducing costs—ultimately transforming how cancer is detected and treated.
Product/Service Information:
The typical end user of OncoSage is a clinician or healthcare provider—such as an oncologist, primary care physician, or diagnostic specialist—who orders blood-based tests to support cancer screening or diagnosis. Its solution is also used by hospitals and health systems integrating early detection into care pathways, and by public health programs seeking scalable, non-invasive screening tools. Ultimately, it serves patients by enabling earlier, more accurate cancer detection through their care providers.
Website
copoly.aiContact
-
Peng Zhang, Chief Executive Officer and Co-FounderTel: +1 778-858-9412Email: peng@copoly.ai
-
-
-
-
-
Event details
Event contact
Participants
-
ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for life… -
Copoly.ai is a Canadian biotechnology and AI company redefining early cancer detection… -
Dalriada is a leading North American partnered discovery company that is pioneering its novel Turn-Key™ model in small… -
DistillerSR is the leading platform for AI powered literature review automation and evidence… -
Northern Vascular Systems (NVS) has pioneered a novel, light-activated gel for treatment of vascular… -
Rapid Novor Inc. is a leading CRO specializing in antibody…